Prediction of Progression-Free Survival in Patients With Multiple Myeloma Following Anthracycline-Based Chemotherapy Based on Dynamic FDG-PET
暂无分享,去创建一个
Ludwig G Strauss | Uwe Haberkorn | Antonia Dimitrakopoulou-Strauss | L. Strauss | A. Dimitrakopoulou-Strauss | U. Haberkorn | M. Hoffmann | R. Bergner | M. Uppenkamp | Martin Hoffmann | Raoul Bergner | Michael Uppenkamp
[1] Antonia Dimitrakopoulou-Strauss,et al. Quantitative studies using positron emission tomography (PET) for the diagnosis and therapy planning of oncological patients. , 2006, Hellenic journal of nuclear medicine.
[2] Leyun Pan,et al. Prediction of Short-term Survival in Patients with Advanced Nonsmall Cell Lung Cancer Following Chemotherapy Based on 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography: A Feasibility Study , 2007, Molecular Imaging and Biology.
[3] L G Strauss,et al. The applications of PET in clinical oncology. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] R. Hustinx,et al. Sequential Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Response to Chemotherapy in Metastatic Breast Cancer , 2006, Clinical Cancer Research.
[5] C Burger,et al. A JAVA environment for medical image data analysis: initial application for brain PET quantitation. , 1998, Medical informatics = Medecine et informatique.
[6] A. Osmont,et al. Determination of 18F-fluoro-2-deoxy-d-glucose rate constants in the anesthetized baboon brain with dynamic positron tomography , 1993, Journal of Neuroscience Methods.
[7] Gary Caputo,et al. Value of FDG PET in the assessment of patients with multiple myeloma. , 2005, AJR. American journal of roentgenology.
[8] A. Anagnostopoulos,et al. Hematological malignancies: myeloma. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[9] Cyrill Burger,et al. Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] C Burger,et al. Requirements and implementation of a flexible kinetic modeling tool. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] A. Waxman,et al. Whole-body (18)F-FDG PET identifies high-risk myeloma. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Louis Sokoloff,et al. Basic Principles Underlying Radioisotopic Methods for Assay of Biochemical Processes in Vivo , 1983 .
[13] A. Fischman,et al. Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.
[14] G. Altavilla,et al. Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] S. Salmon,et al. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.
[16] T. Momose,et al. Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] H. Döhner,et al. Initial results in the assessment of multiple myeloma using 18F-FDG PET , 2002, European Journal of Nuclear Medicine and Molecular Imaging.